Description
The medtech industry’s revenue growth is expected to gradually dip beyond 2020, from a year-on-year growth of about 5.7% in 2020 to 5.3% in 2024. The industry is already addressing this as well as several other challenges such as the changing device ecosystem, shifting competitive focus, and the invasion by technology companies. Medtech players are no longer just suppliers of medical devices. They are, and will continue to play an increasingly growing role of being, solution providers as well. These solutions complement the core products to help their users— i.e., providers and patients, and those who pay for them, including payers—to better manage patient health and outcomes, while reducing costs, thus satisfying the requirements of the quadruple aim of healthcare. Medtech companies are also moving horizontally across the patient care continuum, beyond simply intervention or therapy, to focus on follow-up, as well as diagnosis and even prevention. Enabling this transition are the several digital tools and technologies that are now available and making their headway into the overall healthcare industry.
The medtech industry lags behind its larger healthcare peer, the pharmaceutical industry, and has a lot of room to incorporate digital solutions. The transformation begins from within, as the first pillar of digital transformation for the industry is its own internal operations. The other pillars are care delivery digitization, connected devices, and connected patients – with ample overlaps between the three. While those overlaps are acknowledged, the differences between the three are also crucial to understand. If the potential of the opportunities provided by digital transformation initiatives is achieved to a reasonable estimate, it could add up to $240 billion in revenues on top of the additional forecasts.
Don't have an account? Create One!
Already have an account? Login!
Connect With LinkedIn
Use your Linkedin account to login or register within our store.You're just one click away.